Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_1
2
67%
Ph phase_2
1
33%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (66.7%)
Phase 21 (33.3%)

Trials by Status

completed133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_2

Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina

NCT01966042
unknownphase_1

Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis

NCT00832247
unknownphase_1

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI

NCT00626145

Clinical Trials (3)

Showing 3 of 3 trials
NCT01966042Phase 2

Study Protocol of Intramyocardial Injection of Autologous Bone Marrow Stem Cells for Refractory Angina

Completed
NCT00832247Phase 1

Autologous Bone Marrow Mononuclear Cells in Liver Cirrhosis

Unknown
NCT00626145Phase 1

Long Term Follow-up of Autologous Bone Marrow Mononuclear Cells Therapy in STEMI

Unknown

All 3 trials loaded

Drug Details

Intervention Type
GENETIC
Total Trials
3